Literature DB >> 14978180

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes.

Lesley A Stevens1, Ognjenka Djurdjev, Savannah Cardew, E C Cameron, Adeera Levin.   

Abstract

Current literature suggests associations between abnormal mineral metabolism (MM) to cardiovascular disease in dialysis populations, with conflicting results. MM physiology is complex; therefore, it was hypothesized that constellations of MM parameters, reflecting this complexity, would be predictive of mortality and that this effect would be modified by dialysis duration (DD). Prevalent dialysis patients in British Columbia, Canada, who had measurements of calcium (Ca), phosphate (Pi), and parathyroid hormone (iPTH) between January and March 2000 were followed prospectively until December 2002. Statistical analysis included Cox proportional hazard models with Ca, Pi, and iPTH alone and in combination as explanatory variables; analyses were stratified by DD. The 515 patients included in this analysis represent British Columbia and Canadian dialysis populations: 69% were on hemodialysis, mean age was 60 +/- 17 yr, 40% were female, and 34% had diabetes. Mean Ca and Pi values were 2.32 +/- 0.22 mmol/L and 1.68 +/- 0.59 mmol/L, respectively, and median iPTH was 15.8 pmol/L (25th to 75th percentile: 6.9 to 37.3 pmol/L). Serum Pi, after adjusting for demographic, dialysis type and adequacy, hemoglobin, and albumin, independently predicted mortality (risk ratio [RR], 1.56 per 1 mmol/L; 95% confidence interval [CI], 1.15 to 2.12; P = 0.004). When combinations of parameters were modeled (overall P = 0.003), the combinations of high serum Pi and Ca with high iPTH (RR, 3.71; 95% CI, 1.53 to 9.03; P = 0.004) and low iPTH (RR, 4.30; 95% CI, 2.01 to 9.22; P < 0.001) had highest risks for mortality as compared with the combination of high iPTH with normal serum Ca and Pi that had the lowest mortality and was used as index category. These effects varied across different strata of DD. This analysis demonstrates the importance of examining combinations of MM parameters as opposed to single variables alone and the effect of DD. In so doing, the complex interaction of time and MM can begin to be understand. Further exploration is required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978180     DOI: 10.1097/01.asn.0000113243.24155.2f

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  77 in total

1.  Development of Severe Hyperparathyroidism Despite Short-Term Renal Replacement Therapy.

Authors:  Manabu Okada; Yoshihiro Tominaga; Takahisa Hiramitsu; Toshihiro Ichimori
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

2.  Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients.

Authors:  Harin Rhee; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim
Journal:  Clin Exp Nephrol       Date:  2012-01-05       Impact factor: 2.801

Review 3.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

4.  Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients.

Authors:  Hee Jung Jeon; Yong Chul Kim; Seokwoo Park; Clara Tammy Kim; Jongwon Ha; Duck Jong Han; Jieun Oh; Chun Soo Lim; In Mok Jung; Curie Ahn; Yon Su Kim; Jung Pyo Lee; Young Hoon Kim
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

Review 5.  Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Authors:  János Nemcsik; István Kiss; András Tislér
Journal:  World J Nephrol       Date:  2012-02-06

Review 6.  Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Authors:  David J A Goldsmith; John Cunningham
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

7.  Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Authors:  Min Jun; Jicheng Lv; Vlado Perkovic; Meg J Jardine
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

8.  Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.

Authors:  Melissa Soohoo; Mingliang Feng; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Wei Ling Lau; Jialin Wang; Vanessa A Ravel; Steven Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2016-03-08       Impact factor: 3.754

9.  Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; Tessa C Rue; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2008-11-06       Impact factor: 8.860

10.  Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Authors:  Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.